References
- Vaccarella S, Franceschi S, Engholm G, et al. 50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence. Br J Cancer. 2014;111(5):965–969.
- Dillner J, Sparén P, Andrae B, et al. Livmoderhalscancer ökar hos kvinnor med normalt cellprov. [cited 2019 Jan 16]. Available from: http://lakartidningen.se/Klinik-och-vetenskap/Rapport/2018/06/Livmoderhalscancer-okar-hos-kvinnor-med-normalt-cellprov/.
- Basu P, Ponti A, Anttila A, et al. Status of implementation and organization of cancer screening in The European Union Member States – summary results from the second European screening report. Int J Cancer. 2018;142(1):44–56.
- Elfström KM, Sparén P, Olausson P, et al. Registry-based assessment of the status of cervical screening in Sweden. J Med Screen. 2016;23(4):217–226.
- Hortlund M, Elfström KM, Sparén P, et al. Cervical cancer screening in Sweden 2014–2016. Plos One. 2018;13(12):e0209003.
- Ludvigsson JF, Almqvist C, Bonamy A-K, et al. Registers of the Swedish total population and their use in medical research. Eur J Epidemiol. 2016;31(2):125–136.
- Nationellt Kvalitetsregister för Cervixcancerprevention (NKCx). [cited 2015 Jun 15]. Available from: http://www.nkcx.se/index_e.htm.
- Wang J, Elfström KM, Andrae B, et al. Cervical cancer case–control audit: Results from routine evaluation of a nationwide cervical screening program. Int J Cancer. 2020;146:1230–1240.
- Wang J, Ploner A, Sparén P, et al. Mode of HPV vaccination delivery and equity in vaccine uptake: a nationwide cohort study. Prev Med. 2019;120:26–33.
- Castanon A, Sasieni P. Is the recent increase in cervical cancer in women aged 20–24years in England a cause for concern? Prev Med. 2018;107:21–28.
- NORDCAN. [cited 2019 Jan 1]. Available from: http://www-dep.iarc.fr/NORDCAN/english/frame.asp.